A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state

Journal of Pineal Research

Volumn 23, Issue 1, 1997, Pages 15-19

  Lissoni, P ^a   Paolorossi, F ^a   Ardizzoia, A ^a   Barni, S ^a   Chilelli, M ^a   Mancuso, M ^a   Tancini, G ^a   Conti, A ^b   Maestroni, G J M ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b Istituto di Patologia   (Switzerland)

Author keywords

Cisplatin; Etoposide; Lung cancer; Melatonin

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; MELATONIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; SMALL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MELATONIN; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION;

EID: 0031202122     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.1997.tb00329.x     Document Type: Article

References (16)

1. BLASK, D.E. (1984) The pineal: An oncostatic gland? The Pineal Gland. R.J. Reiter, ed. New York: Raven Press, pp 253-284.
2. CONTI, A., G.J.M. MAESTRONI (1995) The clinical neuroimmunotherapeutic role of melatonin in oncology. J. Pineal Res. 19:103-110.
3. COS, S., D.E. BLASK (1994) Melatonin modulates growth factor activity in MCF-7 human breast cancer cells. J. Pineal Res. 17:25-32.
4. EHRKE, M.J., E. MIHICH, D. BERD, M.J. MASTRANGELO (1989) Effects of anticancer drugs on the immune system in humans. Seminars Oncol. 16:230-253.
5. KLASTERSKY, P., J.P. SCULIER (1985) Chemotherapy of non-small cell lung cancer. Seminars Oncol. 12:36-48.
6. LIN, A.Y., D.C. IHDE (1992) Recent developments in the treatment of lung cancer. J. Amer. Med. Assoc. 267:536-542.
7. LISSONI, P., S. BARNI, S. CRISPINO, G. TANCINI, F. FRASCHINI (1989) Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur. J. Cancer Clin. Oncol. 25:789-795.
8. LISSONI, P., E. TISI, F. BRIVIO, A. ARDIZZOIA, S. CRISPINO, S. BARNI, G. TANCINI, A. CONTI, G.J.M. MAESTRONI (1991) Modulation of interleukin-2-induced macrophage activation in cancer patients by the pineal hormone melatonin. J. Biol. Regul. Homeostat. Agents 5:154-156.
9. LISSONI, P., S. BARNI, A. ARDIZZOIA, F. PAOLOROSSI, S. CRISPINO, G. TANCINI, E. TISI, C. ARCHILI, D. DE TOMA, G. PIPINO, A. CONTI, G.J.M. MAESTRONI (1992) Randomized study with the pineal hormone melatonin versus supportive care alone in advanced non-small cell lung cancer resistant to a first-line chemotherapy containing cisplatin. Oncology 49:336-339.
10. LISSONI, P., S. BARNI, G. TANCINI, F. BRIVIO, E. TISI, B. ZUBELEWICZ, R. BRACZKIWSKI (1994) Role of the pineal gland in the control of macrophage functions and its possible implication in cancer. A study of interactions between tumor necrosis factor-alpha and the pineal hormone melatonin. J. Biol. Regul. Homeostat. Agents 8:126-129.
11. MAESTRONI, G.J.M., A. CONTI, W. PIERPAOLI (1988) Pineal melatonin, its fundamental immunoregulatory role in aging and cancer. Ann. N.Y. Acad. Sci. 521:140-148.
12. MAESTRONI, G.J.M., A. CONTI, P. LISSONI (1994) Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin-4. Cancer Res. 54:4740-4743.
13. REITER, R.J., D.X. TAN, B. POEGGELER, A. MENENDEZ-PELAEZ, L.D. CHEN, S. SAARELA (1994) Melatonin as a free radical scavenger. Implications for aging and age-related diseases. Ann. N.Y. Acad. Sci. 719:1-12.
14. REITER, R.J., D. MELCHIORRU, E. SEWERYNCK, B. POEGGELER, L. BARLOW-WALDEN, J.I. CHUANG, G.G. ORTIZ, D. ACUÑA-CASTROVIEJO (1995) A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18:1-11.
15. ROBERTS, J.J., A.J. THOMSON (1979) The mechanism of action of antitumor platinum compounds. Prog. Nucleic Acid. Res. Mol. Biol. 22:71-133.
16. SMYTHE, G.A., M.C. STUART, I. LAZARUS (1974) Stimulation and suppression of somatomedin activity by serotonin and melatonin. Experientia 30:1356-1358.